摘要
目的:探讨桂枝茯苓胶囊联合米非司酮治疗子宫内膜异位症的临床疗效及其安全性。方法:选取子宫内膜异位症的患者72例,随机分为治疗组和对照组。治疗组给予桂枝茯苓胶囊联合米非司酮治疗,对照组给予非司酮治疗,共3个月。比较两组临床疗效、用药前后症状、体征改善情况,生殖激素的变化,不良反应的发生及停药后的妊娠情况等。结果:治疗组临床疗效要优于对照组,在安全性和副反应与对照组相似。结论:桂枝茯苓胶囊联合米非司酮治疗子宫内膜异位症要优于单独使用米非司酮。
Objective：To explore the clinical effects and safety of cassia tuckahoe capsule combined mifepristone on endometriosis.Method：72 cases with endometriosis were randomly divided into the treatment group and control group in this study,the treatment group was treated with cassia tuckahoe capsule combined mifepristone,and control group was treated with mifepristone,a courses of three months.Comparison of two clinical efficacy,the symptoms and signs to improve the situation,the changes of hormone,adversed events and pregnancy before and after the treatment.Result：The clinical effect of treatment group was superior to the control group,and the safety and side effects were similar to the control group.Conclusion：The clinical effects of the cassia tuckahoe capsule is superior to the mifepristone singly.
出处
《河北医学》
CAS
2010年第5期578-580,共3页
Hebei Medicine
